Kinetics study of human retrovirus antigens expression in T lymphocytic cell lines by indirect immunofluorescence assay

Viral Immunology

Volumn 10, Issue 3, 1997, Pages 149-157

  Gallego, Sandra ^a   Recalde, Alejandra ^a   Gastaldello, Rene ^a   Isa, Maria ^a   Nates, Silvia ^a   Medeot, Silvia ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOFLUORESCENCE; KINETICS; NONHUMAN; RETROVIRUS; RETROVIRUS INFECTION; SERODIAGNOSIS; SERUM; T LYMPHOCYTE;

HTLV; HTLV I; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; UNIDENTIFIED RETROVIRUS;

EID: 0030724124     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1997.10.149     Document Type: Article

References (25)

1. Bartholernew, C., W.C. Saxinger, J.W. Clark, M. Gail, A. Dudgeon, B. Mahabir, B. Hull-Drysdale, F. Cleghorn, R.C. Gallo, and W.A. Blattner. 1987. Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA 257:2604-2608.
2. Blattner, W.A. 1989. Retroviruses. In A.S. Evans (ed): Viral Infections of Human: Epidemiology and Control, 3rd ed. Plenum, New York
3. Carlson, J.R., J. Yee, S.H. Hinrichs, M.L. Bryant, M.B. Garden, and N.C. Pedersen. 1987. Comparison of indirect immunofluorescence and Western blot for detection of anti-human immunodeficiency virus antibodies. J. Clin. Microbiol. 25:494-497.
4. Cortes, E., R. Detels, D. Aboulafia, et al. 1989. HIV-1, HIV-2 and HTLV-1 infection in high risk groups in Brazil. N. Engl. J. Med. 320:953-958.
5. Faurel, M., and G. Azanne. 1989. Immunofluorescence assay for human immunodeficiency virus antibody: investigation of cell fixation for virus inactivation and antigen preservation. J. Clin Microbiol. 27:1810-1813.
6. Forghani, B., J. Hurst, and C. Chan. 1991. Advantages of a human immunodeficiency virus type I (HIV-1) persistently infected Hela T4+ cell line for HIV-1 indirect immunofluorescence serology. J. Clin. Microbiol. 29:2266-2272.
7. Gallo, D., J. Diggs, G. Kshell, P. Darley, M. Huffman, and J. Riggs. 1986. Comparison of detection of antibody to the acquired immune deficiency syndrome virus by enzyme immunoassay, immunofluorescence, and Western blot methods. J. Clin. Microbiol. 23:1049-1051.
8. Gessain, A., F. Barin, J.C. Vernant, et al. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407-410.
9. Hinuma, Y., K. Nagata, M. Hanaoka, et al. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 78:6476-6480.
10. Hjelle, B., O. Appenzeller, R. Mills, et al. 1992. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 339:645-646.
11. Kaminsky, L., D.T. McHugh, P.V. Stites, G. Henle, and J. Levy. 1985. High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. Proc. Nat. Acad. Sci. USA 82:5535-5539.
12. Kawano, F., K. Yamaguchi, H. Nishimura, H. Tsuda, and K. Takatsuki. 1985. Variation in the clinical sources in adult T-cell leukemia. Cancer 55:851-856.
13. Khabbaz, R., W. Heneine, A. Grindon, T. Hartley, G. Shulman, and J. Kaplan. 1992. Indeterminate HTLV sero-logic results in U.S. blood donors: are they due to HTLV-I or HTLV-II? J. Acq. Immune Defic. Synd. 5:400-404.
14. Kvinesdal, B, C. Nielsen, A. Poulsen, and N. Hojlyng. 1989. Immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 2. J. Clin. Microbiol. 27:2502-2504.
15. Lee, H., P. Swanson, V. Short, J.A. Zack, J.D. Rosenblatt, and I.S.Y. Chen. 1989. High rate of HTLV-II infection in seroposite IV drug abusers in New Orleans. Science 244:471-475.
16. Lennette, E., S. Karpatkin, and J. Levy. 1987. Indirect immunofluorescence assay for antibodies to human immunodeficiency virus. J. Clin. Microbiol. 25:199-202.
17. Lipka, J., K. Young, S. Kwok, G. Reyes, J. Sninsky, and S. Foung. 1991. Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals. Vox Sang 61:171-176.
18. Mahonis, J., K. Rosenthal, M. Chernesky, S. Castriciano, E. Scheid, M. Blajchman, and D. Harnish. 1989. Agreement study between two laboratories of immunofluorescence as a confirmatory test for human immunodeficiency virus type 1 antibody screening. J. Clin. Microbiol. 27:1234-1237.
19. Osame, M., M. Matsumoto, K. Ysuku, et al. 1987. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphocyte virus type I and adult T-cell leukemia-like cells. Ann. Neurol. 21:117-122.
20. Poisez, B.J., F.W. Ruscetti, A.F. Gazdar, P.A. Bunn, J.D. Minna, and R.C. Gallo. 1980. Detection and isolation of type C retroviruses particles from the fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
21. Robert-Guroff, M., S.H. Weiss, J.A. Giron, et al. 1986. Prevalence of antibodies to HTLV-I, II, and III in intravenous drug abusers from an AIDS endemic region. JAMA 255:3133-3137.
22. Sheremata, W., W. Harrington, P. Bradshaw, et al. 1993. Association of "(tropical) ataxic neuropathy" with HTLV-II. Virus Res. 29:71-77.
23. Vercauteren, G., G. Beelaert, and G. van der Groen. 1995. Evaluation of an agglutination HIV-1 + 2 antibody assay. J. Virol. Methods 51:1-8.
24. Vernal, J.C., L. Marus, A. Gessain, F. Barin, O. Gout, J.M. Delaportee, K. Sanhadji, G. Buisson, and G. De The. 1987. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type-I: a clinical and sero-epidemiologic study of 25 cases. Ann. Neurol. 21:123-130.
25. Zaaijer, H., H. Cuypers, C. Wit, and P. Lelie. 1994. Results of 1-year screening of donors in the Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection. Transfusion V34 N10:877-880.